2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Safety and pharmacokinetics of anti-inflammatory NE3107 treatment in carbidopa/levodopa-treated patients with Parkinson’s disease: A phase 2a, double-blind, placebo-controlled study

J. Aldred, R. Rodriguez, E. Rivera-Rivera, S. Isaacson, R. Kumar, A. Ellenbogen, C. Ahlem, C. Reading, J. Palumbo, N. Osman, A. Lang (Spokane, USA)
Safety assessment of pimavanserin in Parkinson’s disease psychosis patients: Evidence from a systematic review and meta-analysis of randomized controlled trials

G. Bano, A. Sharma (New Delhi, India)
Safety in Levodopa/carbidopa Intestinal Gel (LCGI) titration in the Intensive Care Unit (ICU) setting for Parkinson’s Disease (PD) patient with severe dysphagia

N. Lopez Ariztegui, G. Tabar Comellas, MI. Morales Casado, D. Rivero Rodriguez, M. Ennazeh, P. Leal Sanz (Toledo, Spain)
Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial

D. Kern, S. Isaacson, S. Dhanani, J. Aldred, B. Bergmans, D. Santos-Garcia, T. Oeda, F. Gandor, P. Kukreja, L. Bergmann, R. Gupta, S. Talapala, A. Spiegel, T. Kimber (Aurora, USA)
Safety profile of pimavanserin therapy in elderly patients with neurodegenerative disease-related neuropsychiatric symptoms: a Phase 3b study

G. Alva, W. Cubala, A. Berrio, V. Abler, S. Pathak (Costa Mesa, USA)
Safinamide in Parkinson´s Disease. A retrospective study

M. Carmona-Abellan, M. Erburu, A. Cabrera, C. Garcia-Monco, K. Berganzo, B. Huete (Bilbao, Spain)
Salivary α-synuclein in Parkinson’s disease – a pilot study

M. Kaiserova, D. Hrabos, M. Levkova, M. Kavalkova, R. Kopacik, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)
SARS-CoV-2 infection exacerbates the cellular pathology in Parkinson’s disease progression

HN. Choi, BN. Lee, YH. Che, MG. Ko, HM. Seong, MG. Jo, KS. Lyoo, YJ. Kim, SP. Yun (Jin-Ju, Republic of Korea)
Screening and Treatment of Depression in Parkinson’s Disease Within Movement Disorders Centers

C. Marras, D. Weintraub, J. Beck, A. Naito, Z. Meyer, N. Dahodwala, T. Davis, K. Mills, J. Miyasaki, S. Mantri, M. Neault, A. Brown, A. Allen, E. Nelson, H. Liu (Toronto, Canada)
Screening risk of falls in Parkinson’s disease population living in underserved areas

T. Capato, J. Miranda, F. Santos, R. Cury, E. Barbosa (São Paulo, Brazil)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z